Motif Bio plc (AIM: MTFB), a clinical stage biopharmaceutical company, which listed on AIM on 2nd April 2015 has today announced that it intends to raise £22m of new money through the placing of 44,000,000 new ordinary shares at a…
Motif Bio plc (AIM: MTFB), a clinical stage biopharmaceutical company, which listed on AIM on 2nd April 2015 has today announced that it intends to raise £22m of new money…
Exciting developments in the biotech and pharma marketplace spell good times ahead for one of AIM’s new additions. Our exciting weekly round-up covers a range of updates from this week…
With only 2 new arrivals in April 2015 and 13 leavers, including one of the junior market’s largest companies, AIM continues to shrink. Thankfully many of the leavers were non-qualifying…
Access the all latest company comments on Investor's Champion.
Not yet registered? It's free to register. Register now.
Register on Investor's Champion
Access the all latest company comments on Investor's Champion.
Premium Content
Premium content provides more in-depth information on fascinating investment stories and research to help make your money go further.
Access Premium Content through individual credits (we only want you to read what you are interested in) or through an annual subscription, which works out as only 25p per day – a small price to guide you through the investing maze!
Subscription
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
In depth coverage of many of the world’s great companies
Breaking news on potential upcoming disasters
Unique insights from our top research team
Credits
Get access to our premium content for as little as £3.20 per article.